CM Life Sciences, Inc.
CM Life Sciences, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.
Shell Companies
US, New York [HQ]
Cash Flow Statements
2 Records · Starting from 2020In Million USD. Margins, Growth Rates In %
| Metric | 2020 | None | |
|---|---|---|---|
| Operating Activities | |||
| Operating Cash Flow (OCF) | - - | - - | |
| Operating Cash (Net) | - - | - - | |
| Accounts Receivable | - - | - - | |
| Accounts Payable | - - | - - | |
|
Working Capital
|
- - | - - | |
| Change | - - | - - | |
| Other WC | - - | - - | |
| Investing Activities | |||
| Used Cash (Net) | - - | - - | |
| Capital Expenditure | - - | - - | |
| Purchases of Investments | - - | - - | |
| Sale/Maturity of Investment | - - | - - | |
| Property, Plant, Equipment (P&PE) | - - | - - | |
| Acquisitions (Net) | - - | - - | |
| Other Investing Activities | - - | - - | |
| Financing Activities | |||
| Used Cash (Net) | - - | - - | |
| Debt Repayment | - - | - - | |
| Dividends Paid | - - | - - | |
|
Common Stock
|
- - | - - | |
| Issued | - - | - - | |
| Repurchased | - - | - - | |
| Other Financing Activities | - - | - - | |
| Cash Balances | |||
| Begin of Period | - - | - - | |
| End of Period | - - | - - | |
| Change | - - | - - | |
| Non-Cash Balances | |||
| Depreciation and Amortization | - - | - - | |
| Stock Based Compensation | - - | - - | |
| Other | - - | - - | |
| Highlighted metrics | |||
| Free Cash Flow (FCF) | - - | - - | |
| Cash Conversion Cycle (CCC) | - - | - - | |
| Invested Capital | - - | - - | |
|
Other Operating Inflows/Outflows
|
|||
| Forex Effect on Cash | - - | - - |